Literature DB >> 27173507

Haemolytic and nonhaemolytic neonatal jaundice have different risk factor profiles.

Brian K Lee1,2, Isabelle Le Ray2, Ji Yu Sun2, Agneta Wikman3,4, Marie Reilly2, Stefan Johansson5,6.   

Abstract

AIM: This study examined maternal and pregnancy risk factors for haemolytic and nonhaemolytic neonatal jaundice in a large population-based cohort study.
METHODS: We conducted a cohort study of 1 019 220 singleton live births from the Swedish medical birth register from 1987 to 2002, using information on neonatal jaundice and maternal and pregnancy characteristics. Diagnoses of gestational hypertensive disorders were obtained by linkage to the national inpatient register. Multivariate logistic regression analysis provided odds ratios for the risk factors of both forms of jaundice.
RESULTS: A total of 6057 (0.6%) births were affected by haemolytic jaundice and 36 869 (3.6%) by nonhaemolytic jaundice. The strongest risk factors for haemolytic jaundice were maternal alloimmunisation, blood group O and neonatal jaundice in older siblings. For nonhaemolytic jaundice, the strongest risk factors were preterm birth, neonatal jaundice in older siblings, maternal origin from East or South-East Asia and maternal obesity. We estimated that 13% of haemolytic jaundice was attributable to alloimmunisation and 39% of nonhaemolytic jaundice was attributable to preterm birth.
CONCLUSION: Haemolytic and nonhaemolytic neonatal jaundice had different risk factor profiles. Interventions to reduce maternal alloimmunisation, preterm birth and maternal obesity may lower the prevalence of neonatal jaundice and the risk of consequent neurological complications. ©2016 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ABO blood group; Alloimmunisation; Haemolytic hyperbilirubinemia; Nonhaemolytic hyperbilirubinemia; Rhesus negative

Mesh:

Year:  2016        PMID: 27173507     DOI: 10.1111/apa.13470

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  8 in total

Review 1.  Pharmaceutical strategies for preventing toxicity and promoting antioxidant and anti-inflammatory actions of bilirubin.

Authors:  Alessio Nocentini; Alessandro Bonardi; Simone Pratesi; Paola Gratteri; Carlo Dani; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

2.  Estimating risk ratio from any standard epidemiological design by doubling the cases.

Authors:  Yilin Ning; Anastasia Lam; Marie Reilly
Journal:  BMC Med Res Methodol       Date:  2022-05-30       Impact factor: 4.612

3.  An analysis on treatment effect of blue light phototherapy combined with Bifico in treating neonatal hemolytic jaundice.

Authors:  Yan Jiao; Yuting Jin; Huanhuan Meng; Meizhang Wen
Journal:  Exp Ther Med       Date:  2018-06-21       Impact factor: 2.447

4.  Rates of Extreme Neonatal Hyperbilirubinemia and Kernicterus in Children and Adherence to National Guidelines for Screening, Diagnosis, and Treatment in Sweden.

Authors:  Jenny Alkén; Stellan Håkansson; Cecilia Ekéus; Pelle Gustafson; Mikael Norman
Journal:  JAMA Netw Open       Date:  2019-03-01

5.  Evaluation of Associated Markers of Neonatal Pathological Jaundice Due to Bacterial Infection.

Authors:  Yanli Liu; Xiuhua Sun; Yaqiong Wang; Cuihong Xing; Li Li; Shiying Zhou
Journal:  Iran J Public Health       Date:  2021-02       Impact factor: 1.429

6.  Evaluation of a new transcutaneous bilirubinometer in newborn infants.

Authors:  Mikael Norman; Hüseyin Aytug; Hasan Basri Celebi
Journal:  Sci Rep       Date:  2022-04-07       Impact factor: 4.379

7.  The Turkish Neonatal Jaundice Online Registry: A national root cause analysis.

Authors:  Omer Erdeve; Emel Okulu; Ozgur Olukman; Dilek Ulubas; Gokhan Buyukkale; Fatma Narter; Gaffari Tunc; Begum Atasay; Nazli Dilay Gultekin; Saadet Arsan; Esin Koc
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

8.  Indirect neonatal hyperbilirubinemia in hospitalized neonates on the Thai-Myanmar border: a review of neonatal medical records from 2009 to 2014.

Authors:  L Thielemans; M Trip-Hoving; J Landier; C Turner; T J Prins; E M N Wouda; B Hanboonkunupakarn; C Po; C Beau; M Mu; T Hannay; F Nosten; B Van Overmeire; R McGready; V I Carrara
Journal:  BMC Pediatr       Date:  2018-06-12       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.